Impact of COVID-19 Pandemic on Cancer-Related Hospitalizations in Brazil

Imagem de Miniatura
Arquivos
art_COSTA_Impact_of_COVID19_Pandemic_on_CancerRelated_Hospitalizations_in_2021.PDF (1.02 MB)
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS INC
Autores
COSTA, Allini Mafra da
RIBEIRO, Adeylson G.
GINI, Andrea
CABASAG, Citadel
REIS, Rui M.
FREGNANI, Jose Humberto T. G.
SOERJOMATARAM, Isabelle
Citação
CANCER CONTROL, v.28, article ID 10732748211038700, 7p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Alongside the SARS-CoV-2 (COVID-19) pandemic, Brazil also faces an ongoing rise in cancer burden. In 2020, there were approximately 592 000 new cancer cases and 260 000 cancer deaths. Considering the heterogeneities across Brazil, this study aimed to estimate the impact of the COVID-19 pandemic on cancer-related hospital admissions at a national and regional level. Methods The national, regional, and state-specific monthly average of cancer-related hospital admission rates per 100 000 inhabitants and 95% confidence intervals (95% CIs) were calculated from March to July (2019: pre-COVID-19; and 2020: COVID-19 period). Thematic maps were constructed to compare the rates between periods and regions. Results Cancer-related hospital admissions were reduced by 26% and 28% for clinical and surgical purposes, respectively. In Brazil, the average hospitalization rates decreased from 13.9 in 2019 to 10.2 in 2020 per 100,000 inhabitants, representing a rate difference of -3.7 (per 100,000 inhabitants; 95% CI: -3.9 to -3.5) for cancer-related (clinical) hospital admissions. Surgical hospital admissions showed a rate decline of -5.8 per 100,000 (95% CI: -6.0 to -5.5). The reduction in cancer-related admissions for the surgical procedure varies across regions ranging between -2.2 and -10.8 per 100 000 inhabitants, with the most significant decrease observed in the south and southeastern Brazil. Conclusions We observed a substantial decrease in cancer-related hospital admissions during the COVID-19 pandemic with marked differences across regions. Delays in treatment may negatively impact cancer survival in the future; hence, cancer control strategies to mitigate the impact are needed.
Palavras-chave
coronavirus, COVID-19, cancer, Brazil, SUS, hospital admission
URI
https://observatorio.fm.usp.br/handle/OPI/42420
Referências
  1. Alves MR., 2021, POOR SANITATION TRAN
  2. [Anonymous], 2020, LANCET, V395, P1461, DOI 10.1016/S0140-6736(20)31095-3
  3. Bassett MT, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003402
  4. Bong CL, 2020, ANESTH ANALG, V131, P86, DOI 10.1213/ANE.0000000000004846
  5. Brasil. Ministerio da Saude. Informacoes de Saude (TABNET),, 2021, ASS SAUD DAD CONS AI
  6. Breslow N E, 1987, IARC Sci Publ, P1
  7. Coelho FC, 2020, ASSESSING POTENTIAL
  8. Daly C., 2020, CAN J SURG, V63, pS1, DOI 10.1503/cjs.005520
  9. Cardoso CRD, 2021, REV SOC BRAS MED TRO, V54, DOI 10.1590/0037-8682-0713-2020
  10. Dinmohamed AG, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00984-1
  11. do Estado de Goias Governo, PLAN EST CONT ENFR D
  12. do Estado de Rondonia Governo, 2020, PLAN EST CONT
  13. Farley JH, 2020, GYNECOL ONCOL, V158, P25, DOI 10.1016/j.ygyno.2020.05.023
  14. Fonseca GA, 2021, JCO GLOB ONCOL, V7, P4, DOI 10.1200/GO.20.00471
  15. Governo do Estado de Sao Paulo, 2020, PLAN SAO PAUL
  16. Governo do Estado do Ceara, 2019, PLAN EST CONT RESP E
  17. Governo do Estado do Rio Grande do Sul, 2020, PLAN CONT
  18. Greenwood E, 2021, NAT REV CLIN ONCOL, V18, P3, DOI 10.1038/s41571-020-00446-0
  19. Hanna TP, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4087
  20. Instituto Brasileiro de Geografia e Estatistica, 2020, CID EST
  21. Jazieh AR, 2020, JCO GLOB ONCOL, V6, P1428, DOI 10.1200/GO.20.00351
  22. Lobo AD, 2020, INT J INFECT DIS, V97, P382, DOI 10.1016/j.ijid.2020.06.044
  23. London JW, 2020, JCO CLIN CANCER INFO, V4, P657, DOI 10.1200/CCI.20.00068
  24. Maringe C, 2020, LANCET ONCOL, V21, P1023, DOI 10.1016/S1470-2045(20)30388-0
  25. Marques NP., 2021, SEMIN ONCOL, VS0093, P30123
  26. Marson FAL, 2020, PULMONOLOGY, V26, P241, DOI 10.1016/j.pulmoe.2020.04.008
  27. Noronha KVMD, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00115320
  28. Morris EJA, 2021, LANCET GASTROENTEROL, V6, P199, DOI 10.1016/S2468-1253(21)00005-4
  29. QGIS.org, QGIS GEOGR INF SYST
  30. Richards M, 2020, NAT CANCER, V1, P565, DOI 10.1038/s43018-020-0074-y
  31. Saude, 2021, BMDPAINEL COR
  32. Scheffer M, 2018, DEMOGRAFIA MED BRAS
  33. Schrag D, 2020, JAMA-J AM MED ASSOC, V323, P2005, DOI 10.1001/jama.2020.6236
  34. Seth R, 2020, INDIAN PEDIATR, V57, P589, DOI 10.1007/s13312-020-1873-z
  35. Sternberg C, 2020, REV ASSOC MED BRAS, V66, P338, DOI 10.1590/1806-9282.66.3.338
  36. Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
  37. ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507
  38. Vazquez Rosas Tabare, 2021, JCO Glob Oncol, V7, P694, DOI 10.1200/GO.21.00016

Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - ODS/03